NCT03283852 Identifying New Genetic Causes to Development Disorders
| NCT ID | NCT03283852 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild |
| Condition | Disorders of Sex Development |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,100 participants |
| Start Date | 2017-02-21 |
| Primary Completion | 2027-02-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,100 participants in total. It began in 2017-02-21 with a primary completion date of 2027-02-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Disorders of growth, puberty and sex development can have genetic causes. The exome analysis could detect new mutations responsible for these disorders and the frequency of these mutations in these disorders, their association with other malformations.
Eligibility Criteria
Inclusion Criteria: * congenital growth hormone deficiency * puberty disorder * gonadal dysgenesis or anorchia * primary ovarian failure * disorder of sex development * subjects related to a patient with one of the above criteria Exclusion Criteria: * environmental or auto-immune cause
Contact & Investigator
Raja Brauner, PU-PH
PRINCIPAL INVESTIGATOR
Hôpital Fondation A. de Rothschild
Frequently Asked Questions
Who can join the NCT03283852 clinical trial?
This trial is open to participants of all sexes, studying Disorders of Sex Development. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03283852 currently recruiting?
Yes, NCT03283852 is actively recruiting participants. Contact the research team at ayavchitz@for.paris for enrollment information.
Where is the NCT03283852 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT03283852 clinical trial?
NCT03283852 is sponsored by Fondation Ophtalmologique Adolphe de Rothschild. The principal investigator is Raja Brauner, PU-PH at Hôpital Fondation A. de Rothschild. The trial plans to enroll 1,100 participants.